ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
NICNAS MCS Report – final report and submissions
Monday 6 December 2010
Here's the preface and table of contents:
Multiple Chemical Sensitivity: identifying key research needs
A SCIENTIFIC REVIEW OF MULTIPLE CHEMICAL SENSITIVITY: IDENTIFYING KEY RESEARCH NEEDS
Report prepared by the National Industrial Chemicals Notification and Assessment Scheme (NICNAS) and the Office of Chemical Safety and Environmental Health (OCSEH)
What this review is about
Multiple Chemical Sensitivity (MCS) is a term used to describe a condition presenting as a complex array of symptoms linked to low level exposure to chemicals. There is uncertainty about the event(s) and the underlying biological mechanisms that lead to symptoms. This uncertainty has hampered the development of a clinical basis for the diagnosis and treatment of individuals with MCS.
Those with MCS often face situations where their symptoms may be poorly understood or mis-diagnosed, and may be provided with health care that is less than optimal. Difficulties with the diagnosis of MCS are accompanied by a lack of consensus for its treatment other than avoidance of agents that may trigger symptoms.
Significant gaps in understanding MCS, together with community concerns over the presence of chemicals in the environment have led the Australian Department of Health and Ageing (DoHA), through the Office of Chemical Safety and Environmental Health (OCSEH) and the National Industrial Chemicals Notification and Assessment Scheme (NICNAS), to prepare this scientific review of MCS.
Scope of the review
The aim of this review is to examine current scientific research on MCS and to identify priority areas for further study to inform and engage the clinical and scientific research community.
The report therefore examines evidence about:
The report also highlights research efforts and further activities that would enhance diagnosis, treatment and better clinical management practices of MCS in Australia.
Conduct of the review
The review has two key areas of focus. Firstly, it reviews scientific information to identify biologically plausible hypotheses to explain the underlying mechanisms of MCS. The elucidation of the biological basis for MCS will undoubtedly provide direction for clinical diagnosis and improve treatments options for MCS. If the underlying biological mechanism(s) can be determined for MCS, there is potential to not only better treat symptoms but to effect a significant alleviation of the condition.
Secondly, to better support the diagnosis and management of individuals with MCS, the review identifies current diagnosis and treatment practices and gaps in clinical research and medical education in Australia. The review findings point to specific priorities for further scientific and clinical research on MCS.
1 EXECUTIVE SUMMARY
2 UNDERSTANDING MULTIPLE CHEMICAL SENSITIVITY
3 MECHANISMS OF MULTIPLE CHEMICAL SENSITIVITY
4 DIAGNOSIS, TREATMENT AND MANAGEMENT OF MULTIPLE CHEMICAL SENSITIVITY
5 APPENDIX 1 - A SURVEY OF AUSTRALIAN CLINICIANS APPROACHES TO MULTIPLE CHEMICAL SENSITIVITY
6 APPENDIX 2 - VIEWS OF NATIONAL GOVERNMENTS AND PROFESSIONAL MEDICAL ORGANISATIONS
The full report (and submissions) can be downloaded from the NICNAS website:
Alternative download location
If, for any reason, the above downloads become unavailable they can be downloaded on our website:
List of submissions to the Report
Here is NICNAS's full list of submission to their MCS Report:
blog comments powered by Disqus